NUMBER: standardized reference intervals in the Netherlands using a ‘big data’ approach
- 15 September 2018
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 57 (1) , 42-56
Abstract
Background: External quality assessment (EQA) programs for general chemistry tests have evolved from between laboratory comparison programs to trueness verification surveys. In the Netherlands, the implementation of such programs has reduced inter-laboratory variation for electrolytes, substrates and enzymes. This allows for national and metrological traceable reference intervals, but these are still lacking. We have initiated a national endeavor named NUMBER (Nederlandse UniforMe Beslisgrenzen En Referentie-intervallen) to set up a sustainable system for the determination of standardized reference intervals in the Netherlands.Methods: We used an evidence-based ‘big-data’ approach to deduce reference intervals using millions of test results from patients visiting general practitioners from clinical laboratory databases. We selected 21 medical tests which are either traceable to SI or have Joint Committee for Traceability in Laboratory Medicine (JCTLM)-listed reference materials and/or reference methods. Per laboratory, per test, outliers were excluded, data were transformed to a normal distribution (if necessary), and means and standard deviations (SDs) were calculated. Then, average means and SDs per test were calculated to generate pooled (mean±2 SD) reference intervals. Results were discussed in expert meetings.Results: Sixteen carefully selected clinical laboratories across the country provided anonymous test results (n=7,574,327). During three expert meetings, participants found consensus about calculated reference intervals for 18 tests and necessary partitioning in subcategories, based on sex, age, matrix and/or method. For two tests further evaluation of the reference interval and the study population were considered necessary. For glucose, the working group advised to adopt the clinical decision limit.Conclusions: Using a ‘big-data’ approach we were able to determine traceable reference intervals for 18 general chemistry tests. Nationwide implementation of these established reference intervals has the potential to improve unequivocal interpretation of test results, thereby reducing patient harm.Keywords
This publication has 44 references indexed in Scilit:
- The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesInternational Journal of Epidemiology, 2011
- The Association of Alanine Transaminase With Aging, Frailty, and MortalityThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Universal risk factors for multifactorial diseasesEuropean Journal of Epidemiology, 2007
- Low Alanine Aminotransferase Activity in Older People Is Associated with Greater Long‐Term MortalityJournal of the American Geriatrics Society, 2006
- Prospective Study of the Effect of Blood Pressure on Renal Function in Old AgeJournal of the American Society of Nephrology, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical propertiesScandinavian Journal of Clinical and Laboratory Investigation, 2004
- The quest for comparability: Calibration 2000Accreditation and Quality Assurance, 2000
- Aging and the KidneyJournal of Urology, 1998
- Indirect Estimation of Clinical Chemical Reference Intervals from Total Hospital Patient Data: Application of a Modified Bhattacharya ProcedureClinical Chemistry and Laboratory Medicine (CCLM), 1985